1999
DOI: 10.1056/nejm199908123410713
|View full text |Cite
|
Sign up to set email alerts
|

The Need to Revise the Declaration of Helsinki

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
68
0
15

Year Published

2000
2000
2013
2013

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 211 publications
(83 citation statements)
references
References 11 publications
0
68
0
15
Order By: Relevance
“…In 1999, the controversy arising from the trial of zidovudine 2 As commented by Brennan, 3 the use of efficiency as a value exemplifies the tug of the marketplace. In the American context, it was noted that the experience of managed care does not demonstrate that the marketplace is able to tolerate well the principle of commitment to an individual patient or research subject.…”
Section: The Declaration Of Helsinki and Its Revisionsmentioning
confidence: 99%
“…In 1999, the controversy arising from the trial of zidovudine 2 As commented by Brennan, 3 the use of efficiency as a value exemplifies the tug of the marketplace. In the American context, it was noted that the experience of managed care does not demonstrate that the marketplace is able to tolerate well the principle of commitment to an individual patient or research subject.…”
Section: The Declaration Of Helsinki and Its Revisionsmentioning
confidence: 99%
“…according to her, the use of placebo in this study reminded the unethical tuskegee syphilis study (Fairchild & Bayer, 1999). this editorial and other related articles provoked intense discussions and was possibly one of the reasons for subsequent pressure from north-american regulating agencies and researchers (Levine, 1999) to modify the ethical requirements defined in the declaration of Helsinki (1996). their intention was to change the items related to the obligation to provide access to the best health treatments to all volunteers (item 30) in clinical trials carried out in any part of the world, as well as those related to the use of placebo when there exists an efficient treatment.…”
Section: Double-standard In Clinical Researchmentioning
confidence: 85%
“…O mesmo ocorre com outros agravos, tais como tuberculose, hepatites virais, leishmaniose, malária e hanseníase. Entretanto, é inaceitável que tal urgência seja utilizada como justificativa para diminuir os padrões éticos dos ensaios clínicos 3,[13][14][15][16] . Se os pesquisadores são em geral pessoas privilegiadas, muitos dos voluntários estão entre as populações mais vulneráveis do mundo, vivendo em privação, que facilita a sua exploração, com pouca ou nenhuma voz nas decisões sobre onde e como a pesquisa deve ocorrer.…”
Section: A éTica Na Pesquisa Internacional E Na Saúde Globalunclassified